Skip to main content
SpringerLink
Log in

IFN-α-2b + ribavarin more cost effective for hepatitis C

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

IFN-α-2b + ribavarin more cost effective for hepatitis C. Pharmacoecon. Outcomes News 332, 9 (2001). https://doi.org/10.1007/BF03269624

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269624

Keywords

Search

Navigation